Back to results
US 10,881,611 B2Granted
Extracellular vesicles derived from osteoblastic lineage cells for therapeutic and diagnostic use
AssigneeFondazione Città Della Speranza—Onlus
InventorsMaurizio Muraca, Alfredo Cappariello, Anna Maria Teti
Life of this patent
Estimating the term…
Abstract
The present invention relates to RANKL+ cellular vesicles isolated from osteoblastic lineage cells, optionally immortalised, their use for the therapeutic treatment of bone pathologies and for diagnostic purposes, and processes for the production of said vesicles.
Claims2
Loaded extracellular vesicles isolated from osteoblastic lineage cells, optionally wherein the cells are immortalised cells,
- wherein the vesicles comprise RANKL (Receptor Activator of NF-KB Ligand) on one or more membranes of the vesicles;
- wherein the vesicles are loaded with one or more therapeutic agents selected from the group consisting of Mifamurtide, Carboplatin, Cisplatin, Cyclophosphamide, Doxorubicin, Epirubicin, Etoposide, Ifosfamide, Methotrexate, Leucovorin, Raloxifene, Lasoxifene, Bazedoxifene, Bisphosphonates, alendronate, Ibandronic acid, ibandronate, zoledronic acid, and mixtures thereof;
- and
- wherein the loaded extracellular vesicles are osteotropic.
1 more element
Dependencies are inferred from the claim text.